Type: Public
On the web: http://www.bms.com
Employees: 27,000
Employee growth: (3.6%)

Bristol-Myers Squibb (BMS) may be a giant in transition, but its still a pharmaceutical giant. The company's blockbuster cardiovascular lineup includes heart disease drug Plavix and Avapro for hypertension. BMS also makes antipsychotic medication Abilify and HIV treatments Reyataz and Sustiva. Most of the company's sales come from products in the therapeutic areas of cardiovascular, immunoscience, metabolics, neuroscience, oncology, and virology. BMS, which has 12 manufacturing plants worldwide and conducts research and development in four countries, sells its products globally; the US accounts for two thirds of sales.

Key numbers for fiscal year ending December, 2011:
Sales: $21,244.0M
One year growth: 9.0%
Net income: $3,709.0M
Income growth: 19.6%

Officers:
Chairman: James M. (Jim) Cornelius
CEO and Director: Lamberto Andreotti
SVP Global Development and Medical Affairs, Research and Development: Brian Daniels

Competitors:
AstraZeneca
Merck
Roche Holding

© 2012 Hoover's, Inc. All rights reserved.